Learn More
Medchemexpress LLC 2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-λ6-sulfanyl)phenyl]-triazolo[1,5-a]pyrimidin-7-amine | 1282041-94-4 | MFCD28502125 | 415.33 g/mol | C14H12F7N5S | 250 MG

Supplier: Medchemexpress LLC HY100184250MG
DSM265 is a triazolopyrimidine-based research compound that potently inhibits Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH). It exhibits biochemical potency (IC50 8.9 nM) and cellular activity against P. falciparum 3D7 parasites (EC50 4.3 nM), and is used in antimalarial mechanism-of-action and biochemical studies.
- Potent PfDHODH inhibition with an IC50 of 8.9 nM.
- Inhibits P. falciparum 3D7 parasite growth (EC50 4.3 nM).
- Selective for parasite DHODH versus human DHODH.
- Suitable for biochemical and cellular antimalarial assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.